3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Thrombocythemia, Essential
2
Polycythemia Vera
2
Skin Neoplasms
1
Philadelphia Chromosome
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Melanoma
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Infections
1
Hepatitis C
1
Glioma
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Brain Neoplasms
1
Interventions
fludarabine phosphate
28
Peripheral Blood Stem Cell Transplantation
25
Cyclophosphamide
24
Whole-Body Irradiation
22
Busulfan
22
Tacrolimus
19
Mycophenolic Acid
19
Methotrexate
15
Antilymphocyte Serum
13
Cyclosporine
12
Melphalan
9
Filgrastim
9
Cytarabine
9
Etoposide
8
Cord Blood Stem Cell Transplantation
7
fludarabine
6
Thiotepa
6
Methylprednisolone
6
Imatinib Mesylate
5
Granulocyte Colony-Stimulating Factor
5
thymoglobulin
4
merphos
4
Sirolimus
4
Rituximab
4
Radiotherapy
4
Flow Cytometry
4
Dexamethasone
4
Dasatinib
4
Cyclosporins
4
Calcium Dobesilate
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Blast Crisis
×
peginterferon alfa-2a
×
Clear all
No trials found.